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Caspase-11 controls a noncanonical inflammasome that responds to Gram-negative bacteria and certain
pore-forming toxins. Aachoui et al. (2013) and Case et al. (2013) identify a role for caspase-11 in rapid
responses to bacterial pathogens that access the cytosol via vacuolar membrane disruption or the activity
of specialized secretion systems.Cells of the innate immune system detect
microbial infection through membrane-
bound and cytosolic pattern recognition
receptors that enable discrimination
between self and nonself and between
pathogenic and nonpathogenic bacteria.
Activation of caspase-1 plays a key role
in antimicrobial immunity, as caspase-1
mediates a lytic cell death termed pyrop-
tosis that is associated with the secretion
of caspase-1-dependent proinflamma-
tory cytokines (Bergsbaken et al., 2009).
In particular, caspase-1 is required for
the processing and secretion of inter-
leukin-1b (IL-1b) and IL-18. Mechanisms
governing IL-1a release are less clear, as
IL-1a is not directly processed by cas-
pase-1, yet its release is still associated
with caspase-1 activation. Caspase-1
activation occurs through its recruitment
to Nod-like receptor (NLR)-containing
complexes termed inflammasomes,
which have been proposed to be guard-
ians of ‘‘cytosolic sanctity’’ against the
presence of microbial products (Lamkanfi
and Dixit, 2009). NLRs mediate inflamma-
some assembly in response to particular
infection- or stress-associated stimuli
and recruit caspase-1 either through
direct homotypic interactions between
caspase recruitment (CARD) domains or
through an intermediate adaptor protein
known as ASC, which contains a CARD
domain and a Pyrin domain. The Pyrin
domain of ASC allows it to interact both
with the N-terminal Pyrin domain of
certain NLRs such as NLRP3 and the
CARD of caspase-1.
Early work by the group of Junying
Yuan demonstrated a critical role for cas-
pase-11 in caspase-1 activation and alsodemonstrated that caspase-11 was
essential for the induction of endotoxic
shock in vivo (Wang et al., 1998). More
recently, Kayagaki et al. reported that all
Casp1/ mice also lack caspase-11,
due to the generation of the Casp1/
line in the 129 mouse strain background,
which express a mis-spliced and trun-
cated version of the Casp11 messenger
RNA (Kayagaki et al., 2011). This raised
the question of whether phenotypes
initially attributed to caspase-1 were in
fact due to the absence of caspase-11 in
these mice. Intriguingly, Kayagaki et al.
found that Gram-negative bacteria and
certain pore-forming toxins induce a
caspase-11-dependent noncanonical in-
flammasome that contributes to NLRP3-
dependent IL-1b release and also triggers
NLRP3- and caspase-1-independent cell
death and IL-1a release.
The mechanisms underlying caspase-
11-dependent cell death and the
precise contributions of caspase-11 to
caspase-1-dependent and -independent
inflammatory processes remain poorly
understood. One feature of caspase-11
activation in response to Gram-negative
bacteria appears to be the requirement
for LPS-mediated signaling (Broz et al.,
2012; Gurung et al., 2012; Rathinam
et al., 2012). Induction of type I interferon
(IFN) and subsequent type I IFN receptor
(IFNAR) signaling through TLR4, which
recognizes LPS, and the adaptor protein
TRIF upregulates procaspase-11 expres-
sion, and this upregulation is required for
caspase-11 processing and activation.
Nevertheless, basal levels of procas-
pase-11 are still present in TRIF-deficient
cells, suggesting that additional signalsCell Host & Microbe 1play an important role in caspase-11 acti-
vation (Broz et al., 2012). Furthermore,
while type I IFN signaling is sufficient to
induce caspase-11 upregulation and pro-
cessing (Rathinam et al., 2012), LPS treat-
ment or type I IFN treatment alone does
not cause caspase-11-dependent cell
death (Broz et al., 2012), further impli-
cating additional signals in caspase-11
activation.
Two new studies now shed light on
additional mechanisms of caspase-11
activation and demonstrate that cas-
pase-11 responds to bacterial pathogens
that access the host cell cytosol, either via
specialized secretion systems that trans-
locate bacterial products into the host
cytosol or through direct entry of bacteria
into the cytosol after vacuolar lysis (Aa-
choui et al., 2013; Case et al., 2013).
Case et al. analyzed the mechanisms
underlying inflammasome activation by
Legionella pneumophila, which estab-
lishes an intracellular vacuolar niche using
a dot/icm-encoded type IV secretion
system (T4SS) to translocate bacterial
virulence factors into the host cytosol.
Previous studies had demonstrated that
Legionella with a functional T4SS trigger
ASC-dependent IL-1b secretion that is
independent of the flagellin/NAIP5/
NLRC4 inflammasome, but the host
factors involved were unknown. Through
the elegant use of bacterial mutants in
combination with mice lacking various in-
flammasome components or harboring
individual deletions in caspase-1 or cas-
pase-11, Case et al. now demonstrate
that this ASC-dependent pathway
requires caspase-11. They also show
that caspase-11 contributes to a second,3, March 13, 2013 ª2013 Elsevier Inc. 243
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Figure 1. Caspase-11 Activation Detects Bacteria that Access the
Host Cytosol
Either activity of type IV secretion systems, as in the case of Legionella, or
cytosolic entry of bacteria after vacuolar lysis, as in the case of Burkholderia
or vacuolar pathogens that fail to maintain vacuolar integrity, will trigger
caspase-11 activation and caspase-11-dependent cell death. This death is
accompanied by release of IL-1a and is independent of canonical inflamma-
some adapters, sensors, or caspase-1 itself.
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that results in cell death.
Intriguingly, Case et al. show
that Legionella triggers rapid
caspase-11-dependent cell
death in LPS-primed cells
within 4 hr of infection, in
contrast to other Gram-nega-
tive bacterial infections, for
which the caspase-11-
dependent response gener-
ally requires 16–20 hr. This
more rapid caspase-11-
dependent cell death and
cytokine secretion requires
Legionella with a functional
T4SS (Figure 1). Furthermore,
while NLRP3 and ASC were
important for processing of
caspase-1 and IL-1b in
response to flagellin-defi-
cient (DflaA) Legionella,
NLRP3, ASC, and caspase-
1 were dispensable for cas-
pase-11-dependent celldeath and IL-1a release. Additionally,
they find that although IFNAR signaling
is not required for caspase-11 production,
it contributes to caspase-11-dependent
cell death. These observations demon-
strate that caspase-11 plays an important
role in responding to bacterial secretion
systems that translocate bacterial prod-
ucts into the host cytosol. NAIP5/
NLRC4/caspase-1-dependent pyroptosis
in response to flagellin plays an important
role in restricting Legionella replication
both in vivo and in vitro. However,
whether caspase-11-dependent cell
death can also perform this function is
not yet known.
Aachoui et al. make similarly elegant
use of bacterial and host genetic tools to
reveal that bacterial pathogens that enter
the cytosol also trigger an ASC/caspase-
1-independent but caspase-11-depen-
dent cell death that requires TRIF
signaling. This response may therefore
also involve the TRIF-IFNAR axis,
although the contribution of type I IFN
was not specifically investigated. Aachoui
et al. observed that although secretion
of IL-1b in response to two different path-
ogenic species of Burkholderia required
ASC and a combination of NLRP3 and
NLRC4, cytotoxicity in response to
Burkholderia was unaffected, except in
Casp1/Casp11/ cells. Using a combi-
nation of mouse knockouts, small inter-244 Cell Host & Microbe 13, March 13, 2013fering RNA gene silencing, and retroviral
reconstitution, the authors demonstrate
that this cytotoxicity requires caspase-
11 and not caspase-1. Unlike Legionella,
Burkholderia escapes the phagosome
and replicates in the cytoplasm. To test
the possibility that cytosolic entry of
bacterial pathogens is also a trigger for
caspase-11 activation, Aachoui et al.
investigated responses to two normally
vacuolar pathogens, Legionella and
Salmonella typhimurium, that respectively
lacked SdhA and SifA, secreted effector
proteins that maintain vacuolar integrity,
and thus prevent bacterial mislocalization
to the cytosol. Consistent with their
observations with Burkholderia, infection
withDsdhA Legionella orDsifA Salmonella
led to rapid caspase-11-dependent cell
death. Interestingly, in these experiments,
DflaA Legionella did not trigger cell death,
unlike the DflaADsdhA mutant; this is in
contrast to the Case et al. study, which
observed robust caspase-11-dependent
cell death in DflaA Legionella-infected
cells. However, this distinction may be
due to differences in conditions used to
prime the macrophages, as primed and
unprimed macrophages respond differ-
ently to stimuli that activate different
inflammasomes. Caspase-11 was critical
for protection against Burkholderia
infection in vivo, although whether cas-
pase-11-dependent cell death or/andª2013 Elsevier Inc.release of caspase-11-depen-
dent proinflammatory signals
is responsible for this protec-
tion is not yet known.
Together, these two studies
reveal that caspase-11 plays
a key role in the induction of
cell death in response to
a functional Legionella T4SS
in one case, and the entry of
pathogens into the cytosol in
the other case (Figure 1). The
bacterial signal required for
caspase-11 activation and
caspase-11-dependent cell
death remains unknown. In
the case of the Legionella
T4SS, this recognition may
be direct, analogous to the
recognition of flagellin and
structural components of the
type III secretion system by
the NAIP/NLRC4 system.
Alternatively, another bacte-
rial product delivered into thecytosol by the T4SS may be the trigger,
and this product may also be released
by bacterial pathogens that enter the
cytoplasm. Cytosolic bacterial pathogens
trigger inflammasome activation through
AIM2, which contains a DNA binding
domain and a pyrin domain that allows it
to interact with ASC and recruit cas-
pase-1. Previous studies demonstrated
that SdhA-deficient Legionella trigger the
AIM2 inflammasome (Ge et al., 2012).
However, Aachoui et al. find that ASC is
not required for cytotoxicity in response
to cytosolic Legionella, suggesting that
like the NLRP3/ASC inflammasome, the
AIM2/ASC inflammasome is required for
caspase-1 processing and IL-1b secre-
tion, but not for caspase-11-mediated
cell death in response to cytosolic
bacteria.
Both the T4SS of Legionella and vacu-
olar disruption by cytosolic bacteria
trigger some disturbance of the vacuolar
membrane. Thus, caspase-11 could
potentially be triggered not by direct cyto-
solic sensing of bacterial products, but
through sensing of vacuolar membrane
homeostasis. Vacuolar disruption even
in the absence of microbial infection
induces NLRP3 inflammasome activa-
tion (Hornung et al., 2008). Whether
caspase-11 is also triggered under
these conditions is unknown. The nature
of the upstream sensor that triggers
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currently unknown. While TLR4-TRIF-IF-
NAR signaling upregulates caspase-11
expression and induces its processing,
treatment with LPS or type I IFN alone
does not trigger caspase-11-dependent
cytotoxicity. An additional sensor, which
might itself be type I IFN dependent or
independent, that responds to specific
features of bacterial infection might also
be required to induce caspase-11-depen-
dent cell death.
Intriguingly, while caspase-1 can
mediate cell death downstream of canon-
ical inflammasomes, caspase-1 is dis-
pensable for caspase-11-dependent cell
death. Whether caspase-1 and caspase-
11 trigger cell death in the same way
therefore remains an open question,
and indeed, precisely how caspase-1 or
caspase-11 induces cell death is alsoenigmatic. Together, these new studies
shed light on additional signals that acti-
vate caspase-11 during bacterial infection
and establish caspase-11-dependent cell
death as an important effector mecha-
nism for responding to bacterial patho-
gens that access the host cell cytosol.REFERENCES
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Host lipid alterations are centrally involved in Leishmania donovani infection, and infected patients exhibit
hypocholesterolemia. In this issue of Cell Host & Microbe, Ghosh et al. (2013) show that the metalloprotease
GP63 released by L. donovani in the liver cleaves DICER1, inhibiting miR-122 maturation, which regulates
cholesterol metabolism. These events decrease serum cholesterol and promote parasite growth.Protozoan parasites of the genus Leish-
mania are responsible for a spectrum
of human diseases, ranging from self-
healing ulcers to potentially fatal visceral
leishmaniasis (VL), which affect millions
of people worldwide. The parasites are
transmitted to mammals in the promasti-
gote form by infected sand flies. Following
phagocytosis by macrophages, promas-
tigotes differentiate into amastigotes, the
mammalian stage of the parasite, and
replicate inside phagolysosomal com-
partments. Leishmania donovani, the
causative agent of VL, disseminates and
multiplies within mononuclear phago-
cytes of the reticuloendothelial system,
including the liver, spleen, lymph nodes,
and bone marrow. VL can remain asymp-tomatic or subclinical or may take an
acute or chronic course. Heavily infected
patients may develop disease after an
incubation period varying from weeks to
months. Fever and hepatosplenomegaly
are common symptoms. In addition, VL
patients suffer from progressive weight
loss, cachexia, and pancytopenia. Recent
clinical evidence pointed toward an alter-
ation of lipid metabolism in VL patients,
characterized by a marked hypocholes-
terolemia and reduced LDL cholesterol
(Lal et al., 2007).
In this issue, Ghosh and colleagues
(Ghosh et al., 2013) unveil the mecha-
nism(s) responsible for alteration of
cholesterol metabolism in experimental
VL. Cholesterol is an essential lipid forthe life of eukaryotic cells. It is a major
component of biomembranes, as it regu-
lates their fluidity and structural stability
and maintenance. Cholesterol plays
central roles in processes ranging from
signal transduction to hormone synthesis
(Simons and Ikonen, 2000). In addition, it
is involved in inflammation and infectious
disease. Cholesterol biogenesis occurs
in the cytoplasm of liver and intestinal
cells. Its synthesis starts with the con-
densation of three acetate molecules to
hydroxymethylglutarate by the action of
the rate-limiting enzyme hydroxyme-
thylglutaryl-coenzyme A (HMGCoA) re-
ductase. Hydroxymethylglutarate is then
reduced to mevalonate, which in turn is
decarboxylated to a 5-carbon isoprenoid.3, March 13, 2013 ª2013 Elsevier Inc. 245
